Key Insights

Highlights

Success Rate

94% trial completion (above average)

Research Maturity

59 completed trials (52% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

3.5%

4 terminated out of 114 trials

Success Rate

93.7%

+7.1% vs benchmark

Late-Stage Pipeline

29%

33 trials in Phase 3/4

Results Transparency

15%

9 of 59 completed with results

Key Signals

9 with results94% success

Data Visualizations

Phase Distribution

71Total
Not Applicable (29)
Early P 1 (1)
P 1 (3)
P 2 (5)
P 3 (13)
P 4 (20)

Trial Status

Completed59
Recruiting17
Unknown16
Not Yet Recruiting13
Terminated4
Active Not Recruiting3

Trial Success Rate

93.7%

Benchmark: 86.5%

Based on 59 completed trials

Clinical Trials (114)

Showing 20 of 20 trials
NCT07736313Phase 3Not Yet RecruitingPrimary

Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors With Statin for ACS Patients

NCT07348341Recruiting

Coronary Laser Atherectomy Registry From an International Taskforce

NCT07715474Active Not RecruitingPrimary

ALIGN-ACS Pilot Study

NCT07091682Not ApplicableRecruiting

Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold System in the Treatment of Subjects With Long de Novo Lesions

NCT07684742Phase 4Not Yet RecruitingPrimary

Early Single Antiplatelet Therapy After IVUS-Guided PCI in Acute Coronary Syndrome

NCT07675434Not Yet RecruitingPrimary

Prospective Cohort of Acute Cardiology Referrals in an Ambulatory Day-Hospital Setting

NCT06813339Early Phase 1Recruiting

Placebo-controlled Study of Single and Multiple Ascending Doses of UDP-003 in Healthy Human Participants and Followed by an Open-label Patient Cohort

NCT07123181Not ApplicableRecruitingPrimary

Oregano and Basil Leaves and Coronary Artery Disease

NCT00798122Not ApplicableActive Not RecruitingPrimary

Study of Women With Acute Coronary Syndromes and Nonobstructive Coronary Artery Disease

NCT07588295Not ApplicableRecruiting

Local And Systemic Macrophage Activation in Coronary and Peripheral Artery Disease

NCT07582835Phase 3Recruiting

Study of the Long-term Effects of P2Y12 Inhibitor Monotherapy and Coagulation Markers After Percutaneous Coronary Angioplasty.

NCT07579624Not Yet Recruiting

AI-Enhanced Single-Lead ECG Screening for Coronary Stenosis

NCT02117037Not ApplicableCompletedPrimary

Prognostic Value of Biomarkers Associated With Endothelial Progenitor Cells Mobilization in Acute Coronary Syndromes

NCT06845826Not ApplicableRecruitingPrimary

Point-of-Care Troponin Testing in the Emergency Department

NCT07449429Not Yet Recruiting

A Privacy-Preserving OCR-LLM System for Coronary Syndrome Subtyping From Admission HPI: Multicenter Validation in China and the US

NCT06890013RecruitingPrimary

A Prospective, Single-center, Observational Study Aiming to Assess the Predictive Role of Flow Mediated Dilatation in Acute Coronary Syndromes, Combined With Echocardiographic and Biochemical Indices

NCT07440381Phase 3Not Yet RecruitingPrimary

triPle Oral thERapy With Bempedoic Acid vs uSual Care in Early Lipid Management of Patients With acUte coronAry synDromE

NCT07383155Phase 4Not Yet Recruiting

Bivalirudin Versus Heparin During PCI in High Bleeding Risk Patients With Acute Coronary Syndromes

NCT06927739Phase 2RecruitingPrimary

Focused Orticumab Research for Treating Inflammation in Coronary Arteries

NCT07144059Not Yet RecruitingPrimary

Impact of Non-medicalized ECG Practices Initiated by SAMU in Dispatch Strategies

Scroll to load more

Research Network

Activity Timeline